Advances in genetics. Volume 84 /
The field of genetics is rapidly evolving, and new medical breakthroughs are occurring as a result of advances in our knowledge of genetics. This series continually publishes important reviews of the broadest interest to geneticists and their colleagues in affiliated disciplines.
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | , , |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Waltham, MA :
Elsevier Science,
2013.
|
Edición: | First edition. |
Temas: | |
Acceso en línea: | Texto completo Texto completo |
MARC
LEADER | 00000cam a2200000 i 4500 | ||
---|---|---|---|
001 | SCIDIR_ocn900564360 | ||
003 | OCoLC | ||
005 | 20231117044931.0 | ||
006 | m o d | ||
007 | cr |n||||||||| | ||
008 | 131130s2013 mau o 000 0 eng d | ||
040 | |a YDXCP |b eng |e pn |c YDXCP |d OCLCO |d OCLCQ |d OCLCF |d EBLCP |d OPELS |d N$T |d DEBSZ |d OCLCQ |d D6H |d OTZ |d UKBTH |d OCLCQ |d VT2 |d OCLCO |d OCLCQ |d OCLCO | ||
019 | |a 864414797 | ||
020 | |a 9780124077317 |q (electronic bk.) | ||
020 | |a 0124077315 |q (electronic bk.) | ||
020 | |z 9780124077034 | ||
035 | |a (OCoLC)900564360 |z (OCoLC)864414797 | ||
050 | 4 | |a QH430 |b .A38 2013 | |
072 | 7 | |a SCI |x 027000 |2 bisacsh | |
082 | 0 | 4 | |a 576.5 |2 23 |
245 | 0 | 0 | |a Advances in genetics. |n Volume 84 / |c edited by, Theodore Friedmann, Jay C. Dunlap, Stephen F. Goodwin. |
250 | |a First edition. | ||
260 | |a Waltham, MA : |b Elsevier Science, |c 2013. | ||
300 | |a 1 online resource (163 pages) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
520 | |a The field of genetics is rapidly evolving, and new medical breakthroughs are occurring as a result of advances in our knowledge of genetics. This series continually publishes important reviews of the broadest interest to geneticists and their colleagues in affiliated disciplines. | ||
588 | 0 | |a Online resource; title from digital title page (viewed on Apr 3, 2014). | |
505 | 0 | |a Front Cover; Advances in Genetics; Copyright; Contents; Contributors; Chapter One: Diverse Roles for MAPK Signaling in Circadian Clocks; 1. Circadian Clocks; 1.1. The beginning; 1.2. Organization of the circadian clock; 2. MAPK Signaling Pathways; 2.1. General organization; 2.2. ERK MAPK; 2.3. p38 MAPK; 2.4. JNK MAPK; 3. The Function of MAPKs in Circadian Input Pathways; 3.1. ERK MAPK pathway; 3.2. ERK signaling through downstream components; 3.3. ERK MAPK in peripheral tissues; 3.4. p38 MAPK pathway; 3.5. p38 MAPK in peripheral tissues; 3.6. JNK MAPK pathway; 3.7. Summary | |
505 | 8 | |a 4. Endogenous Rhythms in MAPK Activation4.1. ERK in the SCN; 4.2. p38 and JNK MAPK; 4.3. Transcriptional regulation of MAPK components; 4.4. Transcriptional regulation of MAPK components in mammalian peripheral tissue; 4.5. Rhythmic MAPK activity gates input to the circadian clock; 5. MAPKs Modulate the Circadian Oscillator; 5.1. ERK-mediated regulation of the circadian oscillator; 5.2. p38-mediated regulation of the circadian oscillator; 5.3. JNK-mediated regulation of the circadian oscillator; 5.4. Future directions; 6. The Role of MAPK Pathways in Circadian Output; 6.1. ERK MAPK pathway | |
505 | 8 | |a 6.2. p38 MAPK pathway6.3. JNK MAPK pathway; 6.4. Future directions; 7. Concluding Remarks; References; Chapter Two: Stakeholder Views on Returning Research Results; 1. Introduction; 2. What is a Research Result?; 3. Guidelines on Returning Research Results; 3.1. Biobanks; 3.2. Population-based studies; 4. Stakeholder Views; 4.1. Researchers; 4.2. IRBs; 4.3. Research participants; 4.3.1. Vulnerable populations: Children; 4.3.2. Underserved minority populations; 4.3.3. Returning research results to relatives of research participants; 5. Extent and Experience with Returning Research Results | |
505 | 8 | |a 6. Overall Analysis of Stakeholder Positions6.1. Ethical; 6.2. Legal; 7. Additional Points to Consider; 7.1. Informed consent for returning research results; 7.2. Communication of research results; 7.3. Impact of returning results to affected versus healthy participants; 7.4. Provision of follow-up care; 7.5. Cost; 8. Moving Forward; Acknowledgment; References; Chapter 3: Mouse Models of Radiation-Induced Cancers; 1. Introduction; 2. RI Leukemia; 2.1. RF model; 2.2. SJL/J model; 2.3. C3H model; 2.4. CBA model; 2.5. Underlying molecular pathologies of RI leukemia; 3. RI Lymphoma | |
505 | 8 | |a 3.1. C57BL model3.2. BALB/c model; 3.3. NFS model; 3.4. Underlying molecular pathologies of RI lymphoma; 4. RI Lung Cancer; 4.1. C3H model; 4.2. RF model; 4.3. BALB/c model; 4.4. Underlying molecular pathologies of RI lung cancer; 5. RI Breast Cancer; 5.1. BALB/c total body irradiation model; 5.2. BALB/c transplantation model; 5.3. Underlying molecular pathologies of RI breast cancer; 6. Discussion and Conclusions; References; Chapter Four: Genomics of Elite Sporting Performance: What little We Know and Necessary Advances; 1. Introduction | |
650 | 0 | |a Genetics. | |
650 | 6 | |a G�en�etique. |0 (CaQQLa)201-0069234 | |
650 | 7 | |a genetics. |2 aat |0 (CStmoGRI)aat300138822 | |
650 | 7 | |a SCIENCE |x Life Sciences |x Evolution. |2 bisacsh | |
650 | 7 | |a Genetics |2 fast |0 (OCoLC)fst00940117 | |
700 | 1 | |a Friedmann, Theodore, |d 1935- | |
700 | 1 | |a Dunlap, Jay C. | |
700 | 1 | |a Goodwin, Stephen F. | |
776 | 0 | 8 | |i Print version: |a Friedmann, Theodore. |t Advances in Genetics. |d Burlington : Elsevier Science, �2013 |z 9780124077034 |
856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780124077034 |z Texto completo |
856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/00652660/84 |z Texto completo |